Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- P/B of 32.17 — trading above book value
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -355.9%
- Revenue growing at 20% annually
STEREOTAXIS, INC. (STXS) is a Healthcare company operating in Electromedical & Electrotherapeutic Apparatus, listed on the AMEX , with a market capitalisation of $174 million . Key value metrics: P/B ratio 32.17, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
STEREOTAXIS, INC. — Fundamental Analysis Summary
On financial health, STXS shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -355.9% (sector average: -19.8%), and high leverage with a debt-to-equity ratio of 5.43.
StockPik's composite Value Score for STXS is 53/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
STXS reports a solid gross margin of 51.1% (sector average: 33.5%) and a negative operating margin of -69.3%.
STXS shows revenue growing at 20% year-over-year, with earnings growing at 10%.